Patents by Inventor Michael Rudolf Stratton

Michael Rudolf Stratton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
    Patent number: 6045997
    Abstract: The identification and sequencing of the BRCA2 gene is disclosed as well as the amino acid sequence of the corresponding BRCA2 polypeptides. BRCA2 alleles including those with mutations in the BRCA2 gene which are associated with a predisposition to develop cancer, especially breast and ovarian cancer are also disclosed. The present invention further relates to polypeptides encoded by the above nucleic acid. The present invention further relates to uses of much BRCA2 nucleic acid and BRCA2 polypeptides, in particular in the diagnostic, prognostic or therapeutic treatment of cancer.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: April 4, 2000
    Assignees: Duke University, Cancer Research Campaign Technology Limited
    Inventors: Phillip Andrew Futreal, Richard Francis Wooster, Alan Ashworth, Michael Rudolf Stratton